Welcome to LookChem.com Sign In|Join Free

CAS

  • or

15042-01-0

Post Buying Request

15042-01-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • China Biggest Factory Manufacturer Supply 5,6-Isopropylidene-L-ascorbic acid CAS 15042-01-0

    Cas No: 15042-01-0

  • USD $ 1.0-2.0 / Kilogram

  • 100 Kilogram

  • 20 Metric Ton/Month

  • Leader Biochemical Group
  • Contact Supplier

15042-01-0 Usage

Chemical Properties

White Powder

Check Digit Verification of cas no

The CAS Registry Mumber 15042-01-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,0,4 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 15042-01:
(7*1)+(6*5)+(5*0)+(4*4)+(3*2)+(2*0)+(1*1)=60
60 % 10 = 0
So 15042-01-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H12O6/c1-9(2)13-3-4(15-9)7-5(10)6(11)8(12)14-7/h4,7,10-11H,3H2,1-2H3/t4-,7+/m0/s1

15042-01-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (I0507)  (+)-5,6-O-Isopropylidene-L-ascorbic Acid  >98.0%(HPLC)(T)

  • 15042-01-0

  • 5g

  • 690.00CNY

  • Detail
  • TCI America

  • (I0507)  (+)-5,6-O-Isopropylidene-L-ascorbic Acid  >98.0%(HPLC)(T)

  • 15042-01-0

  • 25g

  • 2,560.00CNY

  • Detail
  • Aldrich

  • (301361)  5,6-Isopropylidene-L-ascorbicacid  98%

  • 15042-01-0

  • 301361-5G

  • 771.03CNY

  • Detail

15042-01-0Synthetic route

acetone
67-64-1

acetone

ascorbic acid
50-81-7

ascorbic acid

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
With Amberlite IR-120 for 2h; Heating;100%
With acetyl chloride at 7 - 20℃; for 11h;100%
With acetyl chloride at 40℃; for 2h;95%
2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

ascorbic acid
50-81-7

ascorbic acid

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
With hydrogenchloride; acetone for 1h;100%
With toluene-4-sulfonic acid In acetone100%
With hydrogenchloride In acetone for 1h;96.7%
1,2-dimethoxypropane
7778-85-0

1,2-dimethoxypropane

ascorbic acid
50-81-7

ascorbic acid

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
With toluene-4-sulfonic acid In dimethyl sulfoxide; acetone at 50℃; for 5h;95%
acetyl chloride
75-36-5

acetyl chloride

ascorbic acid
50-81-7

ascorbic acid

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
In acetone at 5 - 20℃; for 22.5h; Inert atmosphere;91%
In potassium hydroxide; acetone77%
In acetone
In acetone at 20℃; for 16h;
In acetone
ascorbic acid
50-81-7

ascorbic acid

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
With trichlorophosphate In acetone at 20℃; for 4h;89%
With copper(II) sulfate; acetone
In acetone
acryloyl chloride
814-68-6

acryloyl chloride

ascorbic acid
50-81-7

ascorbic acid

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane
3,5-O-benzylidene-6-O-t-butyldimethylsilyl-L-xylo-hex-2-ulosonic acid 1,4-lactone 2-hydrate
216872-53-6

3,5-O-benzylidene-6-O-t-butyldimethylsilyl-L-xylo-hex-2-ulosonic acid 1,4-lactone 2-hydrate

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aq. HOAc / 4 h / 80 °C
2: AcCl / 2 h / 18 °C
View Scheme
P2 O5

P2 O5

acetyl chloride
75-36-5

acetyl chloride

ascorbic acid
50-81-7

ascorbic acid

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
In ethyl acetate; acetone
ascorbic acid
50-81-7

ascorbic acid

A

acetone-n-hexane

acetone-n-hexane

B

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
In acetone
Vitamin C
78619-96-2

Vitamin C

acetone
67-64-1

acetone

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
With acetyl chloride at 40℃; for 3h;
dimethyl sulfate
77-78-1

dimethyl sulfate

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

2,3-O-bis-methyl-5,6-O-isopropylidene-L-ascorbic acid
58650-93-4, 66421-65-6, 128142-57-4

2,3-O-bis-methyl-5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
With potassium carbonate In acetone for 3h; Heating;100%
With potassium carbonate In acetone Heating;96%
With potassium carbonate In acetone for 3h; Heating; Yield given;
chloromethyl methyl ether
107-30-2

chloromethyl methyl ether

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

5,6-O-isopropylidene-2,3-di-O-methoxymethyl-L-ascorbic acid

5,6-O-isopropylidene-2,3-di-O-methoxymethyl-L-ascorbic acid

Conditions
ConditionsYield
With potassium carbonate In acetone Heating;98%
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

(2R)-4-[tert-butyl(dimethyl)silyl]oxy-2-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-hydroxy-2H-furan-5-one
653565-84-5

(2R)-4-[tert-butyl(dimethyl)silyl]oxy-2-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-hydroxy-2H-furan-5-one

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; for 14.5h;98%
1-methyl-1-nitrosourea
684-93-5

1-methyl-1-nitrosourea

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

5,6-O-isopropylidene-3-O-methyl-L-ascorbic acid
58650-92-3

5,6-O-isopropylidene-3-O-methyl-L-ascorbic acid

Conditions
ConditionsYield
With potassium hydroxide In methanol at -20℃;97%
5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

(2R)-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl](hydroxy)ethanoic acid
92973-39-2, 136136-17-9

(2R)-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl](hydroxy)ethanoic acid

Conditions
ConditionsYield
With water; dihydrogen peroxide; potassium carbonate at 20℃; for 24h;96%
With palladium 10% on activated carbon; dihydrogen peroxide; calcium carbonate In water at 20 - 40℃;89%
With dihydrogen peroxide; calcium carbonate
1-Bromoheptane
629-04-9

1-Bromoheptane

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

5,6-O-isopropylidene-2-O-heptyl-L-ascorbic acid

5,6-O-isopropylidene-2-O-heptyl-L-ascorbic acid

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran; dimethyl sulfoxide at -10 - 20℃;96%
ethyl bromide
74-96-4

ethyl bromide

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

(R)-5-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-ethoxy-3-hydroxyfuran-2(5H)-one
86404-03-7

(R)-5-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-ethoxy-3-hydroxyfuran-2(5H)-one

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 20℃; for 3h; not specified;95%
With anion exchange resin with multi-iodide anions In N,N-dimethyl-formamide at 20℃;95%
With sodium hydrogencarbonate In dimethyl sulfoxide at 50℃; for 16h;70%
Stage #1: 5,6-O-isopropylidene-L-ascorbic acid With sodium hydrogencarbonate In dimethyl sulfoxide at 20℃; for 0.333333h;
Stage #2: ethyl bromide In dimethyl sulfoxide at 50℃; for 17h;
62%
With sodium hydrogencarbonate In dimethyl sulfoxide at 70℃; for 2h; Reagent/catalyst; Temperature; Solvent;16.2 g
pivaloyl chloride
3282-30-2

pivaloyl chloride

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

(R)-5-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl pivalate

(R)-5-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl pivalate

Conditions
ConditionsYield
Stage #1: pivaloyl chloride With 1H-imidazole In dichloromethane at 20℃; for 1h;
Stage #2: 5,6-O-isopropylidene-L-ascorbic acid In dichloromethane at 20℃;
95%
5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

2,3-O-bis-methyl-5,6-O-isopropylidene-L-ascorbic acid
58650-93-4, 66421-65-6, 128142-57-4

2,3-O-bis-methyl-5,6-O-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
With tetra-(n-butyl)ammonium iodide; potassium hydroxide In water; ethyl acetate at 20℃; for 24h;94%
5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

calcium bis[(2R)-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl](hydroxy)acetate]
98733-24-5

calcium bis[(2R)-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl](hydroxy)acetate]

Conditions
ConditionsYield
With dihydrogen peroxide; calcium carbonate In water at 20 - 50℃; for 4h;92%
With dihydrogen peroxide; calcium carbonate In water at 30 - 40℃; for 0.5h;78%
With dihydrogen peroxide; calcium carbonate In water at 40℃; Ice-bath cooling;
With dihydrogen peroxide; calcium carbonate In water at 25 - 60℃; for 7h;55 mg
Thioctic acid
1077-28-7, 62-46-4

Thioctic acid

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

L-5,6-O-isopropyliden-2-α-lipoyl-ascorbic acid

L-5,6-O-isopropyliden-2-α-lipoyl-ascorbic acid

Conditions
ConditionsYield
With pyridine; dicyclohexyl-carbodiimide In dichloromethane at 20℃;92%
5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

methyl iodide
74-88-4

methyl iodide

5,6-O-isopropylidene-3-O-methyl-L-ascorbic acid
58650-92-3

5,6-O-isopropylidene-3-O-methyl-L-ascorbic acid

Conditions
ConditionsYield
With potassium carbonate In tetrahydrofuran; dimethyl sulfoxide Ambient temperature; 1.) 20 min, 2.) 6 h;91%
With potassium carbonate In tetrahydrofuran; dimethyl sulfoxide at 20℃;91%
With cesium fluoride In dimethyl sulfoxide at 20℃;61%
5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

methyl iodide
74-88-4

methyl iodide

5,6-O-isopropylidene-2-O-methyl-L-ascorbic acid
87804-25-9

5,6-O-isopropylidene-2-O-methyl-L-ascorbic acid

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran; dimethyl sulfoxide at -10 - 20℃;91%
5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

3,4-O-isopropylidene-L-threonic acid calcium salt

3,4-O-isopropylidene-L-threonic acid calcium salt

Conditions
ConditionsYield
Stage #1: 5,6-O-isopropylidene-L-ascorbic acid With calcium carbonate In water at 0℃; for 1h;
Stage #2: With dihydrogen peroxide In water at 0 - 10℃;
Stage #3: With catalase In water at 20℃; for 2h; Product distribution / selectivity;
91%
Stage #1: 5,6-O-isopropylidene-L-ascorbic acid With calcium carbonate In water at 0℃; for 1.25h;
Stage #2: With dihydrogen peroxide In water at 0 - 20℃; for 6h;
Stage #3: With catalase In water Product distribution / selectivity;
89.4%
Stage #1: 5,6-O-isopropylidene-L-ascorbic acid With calcium carbonate In water at 0℃; for 0.5h;
Stage #2: With dihydrogen peroxide In water at 0 - 20℃;
Stage #3: palladium on carbon; pyrographite In water at 50℃; for 0.5h; Product distribution / selectivity;
77%
Stage #1: 5,6-O-isopropylidene-L-ascorbic acid With calcium carbonate In water at 0℃; for 0.5h;
Stage #2: With dihydrogen peroxide In water
Stage #3: palladium on carbon; pyrographite In water at 50℃; for 0.5h; Product distribution / selectivity;
acetyl chloride
75-36-5

acetyl chloride

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

[(2R)-2-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-hydroxy-5-oxo-2H-furan-4-yl] acetate
116565-60-7

[(2R)-2-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-hydroxy-5-oxo-2H-furan-4-yl] acetate

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 2h;90%
With pyridine In dichloromethane Cooling with ice;76.1%
With pyridine In dichloromethane Cooling with ice;76.1%
With pyridine
diethyl sulfate
64-67-5

diethyl sulfate

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

(R)-5-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-ethoxy-3-hydroxyfuran-2(5H)-one
86404-03-7

(R)-5-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-4-ethoxy-3-hydroxyfuran-2(5H)-one

Conditions
ConditionsYield
With triethylamine In ethanol for 2h; Reflux;87.9%
With potassium hydroxide In dimethyl sulfoxide at 80℃; for 2h;16.5 g
5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

(S)-sodium 2,2-dimethyl-1,3-dioxolane-4-carboxylate

(S)-sodium 2,2-dimethyl-1,3-dioxolane-4-carboxylate

Conditions
ConditionsYield
With sodium hypochlorite; ruthenium(IV) oxide In sodium hydroxide at 55 - 60℃; for 0.666667h; pH 8.0;87%
Multi-step reaction with 2 steps
1: aq. H2O2, CaCO3
2: 95 percent / aq. NaOCl, RuCl3, NaOH / 0.5 h / Ambient temperature
View Scheme
Cinnamyl bromide
4392-24-9

Cinnamyl bromide

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

5,6-O-isopropylidene-2-O-trans-cinnamyl-L-ascorbic acid

5,6-O-isopropylidene-2-O-trans-cinnamyl-L-ascorbic acid

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran; dimethyl sulfoxide at -10 - 20℃;87%
5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

(2S,3S)-1,2-O-isopropylidene-1,2,3,4-tetrol
91274-05-4

(2S,3S)-1,2-O-isopropylidene-1,2,3,4-tetrol

Conditions
ConditionsYield
Stage #1: 5,6-O-isopropylidene-L-ascorbic acid With dihydrogen peroxide; potassium carbonate In water at 20℃; Inert atmosphere;
Stage #2: With ethyl iodide In acetonitrile Inert atmosphere; Reflux;
Stage #3: With lithium aluminium tetrahydride In tetrahydrofuran at 20℃; Inert atmosphere;
87%
Multi-step reaction with 3 steps
1: H2O2; K2CO3 / H2O
2: 93 percent / acetonitrile / 82 °C
3: 96 percent / BH3-SMe2; NaBH4
View Scheme
Multi-step reaction with 2 steps
1: 1.) CuSO4, 2.) K2CO3, H2O2, 3.) KI
2: LiAlH4 / tetrahydrofuran
View Scheme
benzyl bromide
100-39-0

benzyl bromide

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

O3-benzyl-O5,O6-(1-methylethylidene)-L-ascorbic acid
86404-07-1

O3-benzyl-O5,O6-(1-methylethylidene)-L-ascorbic acid

Conditions
ConditionsYield
With potassium carbonate In tetrahydrofuran; dimethyl sulfoxide at 20℃;86%
With cesium fluoride In dimethyl sulfoxide at 20℃;62%
With sodium carbonate In acetone for 4h; Reflux;61.8%
C41H67NO5S

C41H67NO5S

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

C43H71NO8

C43H71NO8

Conditions
ConditionsYield
Stage #1: 5,6-O-isopropylidene-L-ascorbic acid With dmap In dichloromethane at 20℃; for 0.25h; Alkaline conditions;
Stage #2: C41H67NO5S In dichloromethane for 0.333333h; Alkaline conditions;
85.1%
acetyl chloride
75-36-5

acetyl chloride

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

5,6-O-Isopropylidene-3-O-acetyl-L-ascorbic acid
116565-56-1

5,6-O-Isopropylidene-3-O-acetyl-L-ascorbic acid

Conditions
ConditionsYield
With pyridine In dichloromethane Ambient temperature; 1.) 20 min, 2.) 2 h;85%
With triethylamine In acetone at 25℃; for 0.0333333h; further reagents and conditions;61 % Spectr.
diethyl sulfate
64-67-5

diethyl sulfate

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

3-o-ethyl-5,6-o-isopropylidene-L-ascorbic acid
1453087-23-4

3-o-ethyl-5,6-o-isopropylidene-L-ascorbic acid

Conditions
ConditionsYield
With sodium hydrogencarbonate In ethanol at 55℃; for 7h;83.4%
benzyl bromide
100-39-0

benzyl bromide

5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

5,6-O-isopropylidene-2-O-benzyl-L-ascorbic acid

5,6-O-isopropylidene-2-O-benzyl-L-ascorbic acid

Conditions
ConditionsYield
With potassium tert-butylate In tetrahydrofuran; dimethyl sulfoxide at -10 - 20℃;83%
5,6-O-isopropylidene-L-ascorbic acid
15042-01-0

5,6-O-isopropylidene-L-ascorbic acid

hemicalcium 3,4-O-isopropylidene-L-threonate

hemicalcium 3,4-O-isopropylidene-L-threonate

Conditions
ConditionsYield
With dihydrogen peroxide; calcium carbonate In water for 3h; Ambient temperature;81%

15042-01-0Relevant articles and documents

Assessing the pKa-Dependent Activity of Hydroxyl Hydrogen Bond Donors in the Organocatalyzed Cycloaddition of Carbon Dioxide to Epoxides: Experimental and Theoretical Study

Yingcharoen, Prapussorn,Kongtes, Chutima,Arayachukiat, Sunatda,Suvarnapunya, Kittipong,Vummaleti, Sai V. C.,Wannakao, Sippakorn,Cavallo, Luigi,Poater, Albert,D' Elia, Valerio

, p. 366 - 373 (2019)

The development of hydrogen bond donors (HBDs) as catalytic moieties in the cycloaddition of carbon dioxide to epoxides is an active field of research to access efficient, inexpensive and sustainable metal-free systems for the conversion of carbon dioxide to useful chemicals. Thus far, no systematic attempt to correlate the activity of a diverse selection of HBDs to their physico-chemical properties has been undertaken. In this work, we investigate factors influencing the catalytic activity of hydroxyl HBDs from different chemical families under ambient conditions by considering the HBDs Br?nsted acidity (expressed as pKa), the number of hydroxyls and structural aspects. As an effect, this study highlights the crucial role of the hydroxyl protons’ Br?nsted acidity in determining the catalytic activity of the HBDs, identifies an ideal range for the hydroxyl HBDs proton acidity (9 a 11) and leads to a revaluation of phenol and to the discovery of a simple ascorbic acid derivative as efficient HBDs for the title cycloaddition reaction. Density functional theory (DFT) calculations show mild reactions barriers for the reaction catalysed by phenol and suggest the occurrence of aggregation between molecules of ascorbic acid as a further factor affecting catalytic activity. (Figure presented.).

Synthesis of new L-ascorbic ferulic acid hybrids

Voisin-Chiret, Anne Sophie,Bazin, Marc-Antoine,Lancelot, Jean-Charles,Rault, Sylvain

, p. 2533 - 2545 (2007)

A feasibility and chemical study of the coupling conditions of L-ascorbic acid with ferulic acid derivatives are described on the basis of the known synergistic effects of mixtures of various antioxidants. Novel L-ascorbic ferulic hybrids linked at the C-3 hydroxyl group were prepared with the aim to protect the alcohol function and the enediol system.

Design, synthesis, and neuroprotective effects of dual-brain targeting naproxen prodrug

Wang, Linhui,Zhang, Li,Zhao, Yi,Fu, Qiuyi,Xiao, Wenjiao,Lu, Runxin,Hai, Li,Guo, Li,Wu, Yong

, (2018)

A new dual-targeting naproxen prodrug conjugated with glucose and ascorbic acid for central nervous system (CNS) drug delivery was designed and synthesized in order to effectively deliver naproxen to the brain. Naproxen could be released from the prepared prodrugs when incubated with various buffers, mouse plasma, and brain homogenate. Also, the prodrug showed superior neuroprotective effect in vivo over naproxen. Our results suggest that chemical modification of therapeutics with warheads of glucose and ascorbic acid represents a promising and efficient strategy for the development of brain targeting prodrugs by utilizing the endogenous transportation mechanism of the warheads.

-

Salomon

, p. 619 (1963)

-

A New Convenient Method for the Synthesis of Chiral C3-Synthons

Emons, Carry H.H.,Kuster, Ben F.M.,Vekemans, Jozef A.J.M.,Sheldon, Roger A.

, p. 359 - 362 (1991)

Routes are described for the facile preparation of protected optically pure D- and L-glyceric acid (1a,b; 2a,b) starting from D-mannitol, D-isoascorbic acid and L-ascorbic acid.The key step is a ruthenium catalyzed oxidative cleavage of the vicinal diols 4a,b or the α-hydroxy acids 7a,b; 10a,b.

Site-Selective Photochemical Fluorination of Ketals: Unanticipated Outcomes in Selectivity and Stability

Capilato, Joseph N.,Pitts, Cody Ross,Rowshanpour, Rozhin,Dudding, Travis,Lectka, Thomas

, p. 2855 - 2864 (2020)

We report a method for the regioselective photochemical sp3 C-H fluorination of acetonide ketals that presents interesting problems in chemical reactivity. The question of why certain products of the reaction are stable while others are not is addressed, as is the question of why only select α-ethereal hydrogen atoms are targeted in the reaction. We demonstrate that the method can be employed to synthesize unprecedented fluorinated sugars and steroids, and it can also be applied toward the fluorination of carbamates. Though some substrates contain up to eight discrete α-ethereal C-H bonds, we observed site-selectivity in each case, prompting us to investigate potential transition states for the reaction. Finally, a remarkable regiochemical switch upon minor structural modification of a diketal is also analyzed.

Cyclohexyl Spiro-Fused α-Hydroxy Tetronic Acid Derivatives From Vitamin C

Poss, A. J.,Brodowski, M. H.

, p. 2505 - 2508 (1989)

The reaction of dienophile 4, prepared from L-ascorbic acid in 5 steps, with various dienes to prepare cyclohexyl spiro-fused α-hydroxy tetronic acid derivatives is reported.

-

v. Vargha

, p. 847 (1932)

-

Synthesis and Biological Evaluation of Ascorbyl-Conjugated Peptide Derivatives as Collagen Synthesis Stimulating Agents in Human Skin Fibroblasts

Park, Kyeong-Yong,Kim, Jiyeon

, p. 2449 - 2456 (2020)

Vitamin C (ascorbic acid) is a widely used agent for anti-aging and whitening in the field of cosmetics. It affects collagen production in skin cells, inhibits melanin synthesis, displays anti-oxidant activity, and improves the immune system. However, vitamin C has limitations in cell permeability and environmental condition such as heating and lighting decrease its stability. Thus, vitamin C derivatives are being developed to overcome these problems. In this study, we synthesized vitamin C derivatives with a succinoyl group at the 2-position and peptides in the form of ester bonds. We then evaluated the cytotoxicity and collagen synthesis activity of these new compounds in human skin fibroblasts. Vitamin C-conjugated peptides were also synthesized in ether and carbamate forms, and the optimal combination conditions of vitamin C and peptides were identified. In addition, collagen synthesis-stimulating activity of vitamin C-conjugated peptides was also evaluated and compared to the effects of vitamin C alone. Based on these results, we confirmed that the ester-bonded vitamin C-conjugated peptide GEKG showed more stimulating effect on the production of collagen and related gene expression than either vitamin C or GEKG alone. This study will provide important information for developing skin health products and other topical cosmetics using vitamin C and peptides.

Novel multifunctional ascorbic triazole derivatives for amyloidogenic pathway inhibition, anti-inflammation, and neuroprotection

Chauthong, Nattapong,Jiaranaikulwanitch, Jutamas,Jiranusornkul, Supat,Nilkosol, Supitcha,Pandith, Hataichanok,Tadtong, Sarin,Thammarat, Phanit,Vajragupta, Opa

supporting information, (2021/06/15)

Alzheimer’s disease (AD) is a common neurodegenerative disorder. The number of patients with AD is projected to reach 152 million by 2050. Donepezil, rivastigmine, galantamine, and memantine are the only four drugs currently approved by the United States Food and Drug Administration for AD treatment. However, these drugs can only alleviate AD symptoms. Thus, this research focuses on the discovery of novel lead compounds that possess multitarget regulation of AD etiopathology relating to amyloid cascade. The ascorbic acid structure has been designated as a core functional domain due to several characteristics, including antioxidant activities, amyloid aggregation inhibition, and the ability to be transported to the brain and neurons. Multifunctional ascorbic derivatives were synthesized by copper (I)-catalyzed azide–alkyne cycloaddition reaction (click chemistry). The in vitro and cell-based assays showed that compounds 2c and 5c exhibited prominent multifunctional activities as beta-secretase 1 inhibitors, amyloid aggregation inhibitors, and antioxidant, neuroprotectant, and anti-inflammatory agents. Significant changes in activities promoting neuroprotection and anti-inflammation were observed at a considerably low concentration at a nanomolar level. Moreover, an in silico study showed that compounds 2c and 5c were capable of being permeated across the blood–brain barrier by sodium-dependent vitamin C transporter-2.

Synthesis of l-ascorbic acid-amino acid-norcantharidin conjugates and their biological activity evaluation in vitro

Wang, Xianheng,Wu, Caoyuan,Zhang, Jidong,Zhao, Changkuo,Zhou, Yiqi

supporting information, (2022/01/06)

Three components of L-ascorbic acid, amino acid and functionalized norcantharidins were constructed together in several steps to form 42 norcantharidin derivatives in a high yield. The structure of these synthesized l-ascorbic acid-amino acid-norcantharidin conjugates are determined by 1HNMR, 13CNMR and MS spectrum. The results showed that compounds 6e, 6g, 6j, 6l, 6m, 6b, 6e, 6i, and 6n showed high cytotoxicity to HepG2 and compounds 6b, 6e-g, 6l, 6n, 7b, 7d, 7h, 7i, 7n, 8g, 8i exhibited high cytotoxicity to SW480; Meanwhile, besides 6b, 6e, 6g, and 6k, the other compounds showed less toxic to LO2 at a concentration of 50 μg/mg after 72 h. Compound 6g can induce Mφ-type macrophages derived from mouse bone marrow to polarize to M1-type macrophages.

Cosmetic composition having the effect of promoting collagen synthesis and inhibiting reactive oxygen species

-

Paragraph 0068; 0103; 0106, (2021/06/22)

The present invention relates to a novel compound ascombi and its use for improving wrinkles.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15042-01-0